A new study in Small presents a nanoparticle-based delivery system combining CuET and BIO for treating resistant melanoma, ...

Memorial Sloan Kettering Cancer Center investigators report that T cell interferon-γ (IFNγ) orchestrates a ...

As people age, their immune systems become less efficient, posing a challenge for cancer therapies that rely on harnessing ...

During a live event, Nathan M. Denlinger, DO, MS, discussed the PILOT and ALYCANTE trials of CAR T-cell therapy in transplant-ineligible B-cell lymphoma.

Astrocytes are recognized as key regulators of neuroimmune interactions, significantly contributing to both the development ...